GK and hyperinsulinemic hypoglycemia: A similar situation to the pharmacological activation of GK is seen in some cases of persistent hyperinsulinemic hypoglycemia of infancy where a mutation in GK lowers its S0.5 for glucose, which can lead to beta-cell dysfunction and diabetes later in life (77).